Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings
NCT ID: NCT06364137
Last Updated: 2025-09-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
41 participants
INTERVENTIONAL
2024-07-01
2025-09-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings
NCT07155707
Behavioral Telehealth in Low-resource Primary Care Settings for Anxiety and Depression in Youth
NCT06273982
Brief Internet-delivered Intervention for Children and Adolescents With Anxiety and Depression Symptoms
NCT05139433
Telepsychotherapy for the Treatment of Adolescents With Trichotillomania
NCT03725163
Video-visit Behavior Therapy for Anxiety and Depression in Youth
NCT05417412
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Engagement will be assessed using well-established measures - PRIME-O (modified) video coding (session 1), MTT-Y/MTTCG (sessions 1, 4) and attendance data (sessions 1-4). Clinicians in the study will deliver therapy to clients for 4 sessions, providing opportunity to measure temporal sustainment of any engagement differences.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Teleo
Participants in this group will under therapy for 4 sessions using the Teleo virtual therapy video platform, sessions will be recorded and questionnaires and clinical data will be measured.
Teleo
Therapist-led psychotherapy sessions implemented within the Teleo virtual therapy platform.
Standard videoconferencing
Participants in this group will under therapy for 4 sessions using standard video platforms (e.g. zoom or other publicly available product), sessions will be recorded and questionnaires and clinical data will be measured.
Standard videoconferencing
Therapist-led psychotherapy sessions implemented in standard (non-Teleo) video platform
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Teleo
Therapist-led psychotherapy sessions implemented within the Teleo virtual therapy platform.
Standard videoconferencing
Therapist-led psychotherapy sessions implemented in standard (non-Teleo) video platform
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Likely have at least 12 sessions remaining.
* Diagnosis of a mental health condition by a licensed clinician
Exclusion Criteria
5 Years
14 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
MainSquare Co. (dba 'Teleo')
UNKNOWN
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Hong
Associate Professor of Psychiatry and Behavioral Sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David S Hong, MD
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
73203
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.